Health ❯ Healthcare ❯ Reproductive Health

Abortion

Medication Abortion Mifepristone Access to Abortion Legislation Abortion Access Abortion Laws Legal Issues Telehealth Abortion Statistics Medical Abortion Legal Aspects Late-Term Abortion Abortion Pills Voluntary Interruption of Pregnancy Abortion Policies Abortion Bans Mifepriston Legal Aspects of Abortion Voluntary Termination of Pregnancy Medication Abortions Emergency Abortion Planned Parenthood Access to Care Abortion Clinic Abortion Statistics Telehealth Public Opinion Abortion Rights Personal Experiences Complications Abortion Procedure Pro-Abortion Agenda Emergency Abortions Abortion Restrictions Emergency Abortion Cases Fetal Health Legislation Impact Self-Managed Abortion Telemedicine Ectopic Pregnancy Pregnancy Abortion Procedures Women's Health Maternal Mortality Abortion Drugs Legal Restrictions Personal Stories Restrictive Abortion Laws Trends Financial Burdens Ulipristal Acetate Anti-Abortion Activism Personal Choices Medically Indicated Abortions State Abortion Bans Access Elective Abortions Government Regulation Maternal Care Abortion Exceptions Abortion Politics Abortion Providers Civil Rights Methods Access to Abortion Services Abortion Clinics Emotional Impact Demographics Medical Procedures Emergency Medical Care Third Trimester Abortion Contraception Miscarriage Management Mental Health Voluntary Interruption of Pregnancy (IVG) Trends in Abortion Access Mifépristone Early Abortion Chemical Abortion Psychological Impact Patient Rights Legal Rights Public Perception Maternal Health Chemical Abortion Drugs Consumer Protection Medication Abortion Pill Reversal Telehealth Services Access to Services Abortion Pill Online Abortion Services Procedures Health Risks Public Awareness Policy Changes Miscarriage Care Spontaneous Abortion Late Abortions Down Syndrome

Overton Dodges Key Science Questions at Senate FDA Hearing

Her pledge to make the FDA’s mifepristone safety review an immediate priority comes as the agency must report to a court on Oct. 7.

South Korea Plans Phased Rollout of Abortion Pills by Q1 2027

14 Republican Attorneys General Ask EPA To Add Mifepristone To Contaminant Candidate List

Unredacted Autopsy Shows Colorado Teen Died From DIC After Planned Parenthood Abortion

JAMA Study Links Abortion Bans to Declines in Evidence‑Based Miscarriage Care

Supreme Court Weighs Mifepristone Mail Access as Temporary Stay Nears Deadline

Supreme Court Weighs Emergency Bid to Keep Abortion Pill by Mail After 5th Circuit Block

Supreme Court Temporarily Restores Mail and Telehealth Access to Mifepristone

Planned Parenthood Reports Record Abortions, Higher Tax Funding, and a Net Loss

Poll Finds Broad Support to Restore In‑Person Rules for Abortion Pills

Telehealth Fuels Surge in Massachusetts Abortions, With Nonresidents Now the Majority

EU Opens Path to Use Social Fund for Abortion Access After Citizens’ Initiative

DOJ Seeks Pause of Louisiana Abortion-Pill Lawsuit as FDA Reopens Mifepristone Review

Kentucky AG Launches Probe Into Alleged Abortion Pill Ads, Subpoenas Six Gas Stations

Senate Abortion-Pill Hearing Goes Viral After Witness Declines to Say Whether Men Can Get Pregnant

Republicans Push to Restore In‑Person Rules for Abortion Pill at Fiery Senate Hearing

Florida Sues Planned Parenthood Over ‘Safer Than Tylenol’ Abortion Pill Claim, Seeks $350 Million

FDA Opens Mifepristone Safety Review as 20 States Vow to Defend Access

FDA Opens Mifepristone Safety Review as Republicans Move to Curb Mail and Telehealth Access

Planned Parenthood of Wisconsin to Halt Abortion Scheduling Oct. 1 Under Medicaid Funding Restriction